| DI |
2025-09-10 |
2025-09-08 |
KVYO |
Klaviyo, Inc. |
SUMMIT INVESTORS GE IX/VC IV (UK), L.P. |
10% |
S - Sale |
$31.87 |
-4.00M |
0 |
-100% |
-$127.48M |
| DI |
2025-09-10 |
2025-09-08 |
KVYO |
Klaviyo, Inc. |
SUMMIT INVESTORS GE IX/VC IV (UK), L.P. |
10% |
C - Cnv Deriv |
— |
+4.00M |
4.00M |
New |
— |
| DI |
2025-06-05 |
2025-06-04 |
KVYO |
Klaviyo, Inc. |
SUMMIT INVESTORS GE IX/VC IV (UK), L.P. |
10% |
S - Sale |
$33.35 |
-4.00M |
0 |
-100% |
-$133.40M |
| DI |
2025-06-05 |
2025-06-04 |
KVYO |
Klaviyo, Inc. |
SUMMIT INVESTORS GE IX/VC IV (UK), L.P. |
10% |
C - Cnv Deriv |
— |
+4.00M |
4.00M |
New |
— |
| DI |
2025-03-17 |
2025-03-14 |
KVYO |
Klaviyo, Inc. |
SUMMIT INVESTORS GE IX/VC IV (UK), L.P. |
10% |
S - Sale |
$32.44 |
-2.00M |
0 |
-100% |
-$64.88M |
| DI |
2025-03-17 |
2025-03-14 |
KVYO |
Klaviyo, Inc. |
SUMMIT INVESTORS GE IX/VC IV (UK), L.P. |
10% |
C - Cnv Deriv |
— |
+2.00M |
2.00M |
New |
— |
| DI |
2024-11-18 |
2024-11-14 |
KVYO |
Klaviyo, Inc. |
SUMMIT INVESTORS GE IX/VC IV (UK), L.P. |
10% |
S - Sale |
$36.20 |
-3.15M |
346.7K |
-90% |
-$114.15M |
| DI |
2024-11-18 |
2024-11-14 |
KVYO |
Klaviyo, Inc. |
SUMMIT INVESTORS GE IX/VC IV (UK), L.P. |
10% |
C - Cnv Deriv |
— |
+3.50M |
3.50M |
New |
— |
| DI |
2024-08-30 |
2024-08-28 |
KVYO |
Klaviyo, Inc. |
SUMMIT INVESTORS GE IX/VC IV (UK), L.P. |
10% |
C - Cnv Deriv |
— |
+27.4K |
27.4K |
New |
— |
| DI |
2024-08-30 |
2024-08-28 |
KVYO |
Klaviyo, Inc. |
SUMMIT INVESTORS GE IX/VC IV (UK), L.P. |
10% |
S - Sale |
$31.68 |
-27.4K |
0 |
-100% |
-$869.5K |
|
2024-05-29 |
2024-05-24 |
LFST |
LifeStance Health Group, Inc. |
SUMMIT INVESTORS GE IX/VC IV (UK), L.P. |
10% |
S - Sale |
$5.89 |
-3.80M |
41.93M |
-8% |
-$22.40M |
| DI |
2023-10-23 |
2023-10-23 |
KVYO |
Klaviyo, Inc. |
SUMMIT INVESTORS GE IX/VC IV (UK), L.P. |
10% |
S - Sale |
$28.32 |
-1.77M |
0 |
-100% |
-$50.14M |
| DI |
2023-10-23 |
2023-10-23 |
KVYO |
Klaviyo, Inc. |
SUMMIT INVESTORS GE IX/VC IV (UK), L.P. |
10% |
C - Cnv Deriv |
— |
+1.77M |
1.77M |
New |
— |